| Trial ID: | L6013 |
| Source ID: | NCT01792323
|
| Associated Drug: |
Insulin Lispro
|
| Title: |
Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Insulin LISPRO
|
| Outcome Measures: |
Primary: tmax(GIR); time to maximum glucose infusion rate, 8 hours | Secondary: GIRmax, maximum glucose infusion rate, 8 hours | Other: tmax(ins), time to maximum observed plasma insulin lispro concentration, 8 hours
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Graz | Collaborators: European Commission
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2011-08
|
| Completion Date: |
2014-01
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-26
|
| Locations: |
Medical University of Graz, Graz, Styria, A-8036, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01792323
|
